These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9018094)

  • 41. The camptothecin derivative CPT-11 inhibits angiogenesis in a dual-color imageable orthotopic metastatic nude mouse model of human colon cancer.
    Ji Y; Hayashi K; Amoh Y; Tsuji K; Yamauchi K; Yamamoto N; Tsuchiya H; Tomita K; Bouvet M; Hoffman RM
    Anticancer Res; 2007; 27(2):713-8. PubMed ID: 17465193
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro comparative study of the antitumor effects of human interferon-alpha, beta and gamma on the growth and invasive potential of human melanoma cells.
    Horikoshi T; Fukuzawa K; Hanada N; Ezoe K; Eguchi H; Hamaoka S; Tsujiya H; Tsukamoto T
    J Dermatol; 1995 Sep; 22(9):631-6. PubMed ID: 8537547
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antiproliferative effects of interferons on human melanoma cells in the human tumor colony-forming assay.
    Schiller JH; Willson JK; Bittner G; Wolberg WH; Hawkins MJ; Borden EC
    J Interferon Res; 1986 Dec; 6(6):615-25. PubMed ID: 2437222
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
    Maki H; Hojo K; Tanaka H; Sawada TY; Maekawa R; Yoshioka T
    Clin Exp Metastasis; 2002; 19(6):519-26. PubMed ID: 12405289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperthermia effects on the growth of a laryngeal squamous cell carcinoma cell line treated with recombinant human interferons alpha and gamma.
    Park RI; Richtsmeier WJ
    Otolaryngol Head Neck Surg; 1989 Nov; 101(5):542-8. PubMed ID: 2512532
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.
    Hand AM; Husgafvel-Pursiainen K; Pelin K; Vallas M; Suitiala T; Ekman A; Mattson M; Mattson K; Linnainmaa K
    Anticancer Drugs; 1992 Dec; 3(6):687-94. PubMed ID: 1288739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.
    Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synergistic antitumor interactions between newly synthesized ruthenium complexes and cytokines in human colon carcinoma cell lines.
    Kreuser ED; Keppler BK; Berdel WE; Piest A; Thiel E
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):73-81. PubMed ID: 1373006
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Inhibitory effects of CPT-11 on liver metastases in nude mice injected with human pancreatic tumor cells into their spleens].
    Takeda S; Kono A
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2433-6. PubMed ID: 2260878
    [No Abstract]   [Full Text] [Related]  

  • 50. Evidence for involvement of TNF-alpha in the induction phase and IFN-beta in the effector phase of antiproliferative activity of splenic macrophages.
    Stout RD; Suttles J
    Cell Immunol; 1992 Feb; 139(2):363-74. PubMed ID: 1733508
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Camptothecin analogs in malignant gliomas: comparative analysis and characterization.
    Sampath P; Amundson E; Wall ME; Tyler BM; Wani MC; Alderson LM; Colvin M; Brem H; Weingart JD
    J Neurosurg; 2003 Mar; 98(3):570-7. PubMed ID: 12650430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11.
    Gliniak B; Le T
    Cancer Res; 1999 Dec; 59(24):6153-8. PubMed ID: 10626806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models.
    Alami N; Page V; Yu Q; Jerome L; Paterson J; Shiry L; Leyland-Jones B
    Growth Horm IGF Res; 2008 Dec; 18(6):487-96. PubMed ID: 18502161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018).
    Lam W; Jiang Z; Guan F; Hu R; Liu SH; Chu E; Cheng YC
    BMC Complement Altern Med; 2014 Dec; 14():490. PubMed ID: 25510341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib ("Iressa") and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells.
    Koizumi F; Kanzawa F; Ueda Y; Koh Y; Tsukiyama S; Taguchi F; Tamura T; Saijo N; Nishio K
    Int J Cancer; 2004 Jan; 108(3):464-72. PubMed ID: 14648715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor effects with apoptotic death in human promyelocytic leukemia HL-60 cells and suppression of leukemia xenograft tumor growth by irinotecan HCl.
    Chen YL; Chueh FS; Yang JS; Hsueh SC; Lu CC; Chiang JH; Lee CS; Lu HF; Chung JG
    Environ Toxicol; 2015 Jul; 30(7):803-15. PubMed ID: 24474168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.
    Hardman WE; Moyer MP; Cameron IL
    Br J Cancer; 1999 Oct; 81(3):440-8. PubMed ID: 10507768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines.
    Garrison JI; Berens ME; Shapiro JR; Treasurywala S; Floyd-Smith G
    J Neurooncol; 1996 Dec; 30(3):213-23. PubMed ID: 8943096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
    Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
    Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages.
    Bruns CJ; Shinohara H; Harbison MT; Davis DW; Nelkin G; Killion JJ; McConkey DJ; Dong Z; Fidler IJ
    Cancer Res; 2000 Jan; 60(1):2-7. PubMed ID: 10646841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.